Scholarlink

Background <p>The aim of the current study is to identify the possible protective effect of obeticholic acid (OCA) on placental injury caused by cyclophosphamide (CP). OCA was administered in the presence and absence of CP.</p> Methods <p>Thirty-two pregnant female rats were randomly assigned to four groups: control group, OCA group: received OCA (10&#xa0;mg/kg /day, orally), CP group: received CP 20&#xa0;mg/kg intraperitoneally at 12th day, OCA + CP group. Placental weight and placental growth factor (PlGF) were measured. Placental oxidative stress parameters (malondialdahide (MDA) and total antioxidant capacity (TAC)), besides Sirtuin type 1 (SIRT1), nuclear factor erythroid 2-related factor 2 (Nrf2), myeloid differentiation factor 88 (Myd88) and caspase-3 biomarkers, were evaluated. Nuclear factor-kappa B (NF-κB) and tumor necrosis factor-alpha (TNF-α) gene expression were also measured. Placental histopathological examination, toll- like receptor4 (TLR4) and forkhead-box transcription factor1 (FOXO1) immunohistochemical study were performed.</p> Results <p>CP significantly decreased PlGF, placental weight, TAC, SIRT1 and Nrf2 with increased placental MDA, Myd88, caspase-3, NF-κB and TNF-α. Histopathological findings of placental damage and high TLR4, FOXO1 immunoexpressions were detected. OCA significantly increased PlGF level, placental weight and normalized the distributed oxidative stress, inflammatory, and apoptotic biomarkers with a prompt improvement in the histopathological picture and decrease TLR4 and FOXO1 immunoexpressions.</p> Conclusion <p>Accordingly, these findings suggest that OCA protects CP-induced placental injury by modulating TLR4/Myd88/NF-κB; SIRT1-dependant signaling pathways.</p> Graphic abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Obeticholic acid prevents cyclophosphamide-induced placental injury via SIRT1 and TLR4/NF-κB pathways

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月19日

查看全文
  • Walaa Yehia Abdelzaher,
  • Hanaa Mohamed Khalaf,
  • Sara M. Ahmed,
  • Mina Ezzat Attya,
  • Abdelaleem Abdelnour Mohamed,
  • Asmaa Mohamed Mahmoud Ali,
  • Shereen S. Gaber,
  • Ahmed K. A. Abdel-Hakeem,
  • Enas Mostafa Mohammed,
  • Marwa Hassan

摘要

Background

The aim of the current study is to identify the possible protective effect of obeticholic acid (OCA) on placental injury caused by cyclophosphamide (CP). OCA was administered in the presence and absence of CP.

Methods

Thirty-two pregnant female rats were randomly assigned to four groups: control group, OCA group: received OCA (10 mg/kg /day, orally), CP group: received CP 20 mg/kg intraperitoneally at 12th day, OCA + CP group. Placental weight and placental growth factor (PlGF) were measured. Placental oxidative stress parameters (malondialdahide (MDA) and total antioxidant capacity (TAC)), besides Sirtuin type 1 (SIRT1), nuclear factor erythroid 2-related factor 2 (Nrf2), myeloid differentiation factor 88 (Myd88) and caspase-3 biomarkers, were evaluated. Nuclear factor-kappa B (NF-κB) and tumor necrosis factor-alpha (TNF-α) gene expression were also measured. Placental histopathological examination, toll- like receptor4 (TLR4) and forkhead-box transcription factor1 (FOXO1) immunohistochemical study were performed.

Results

CP significantly decreased PlGF, placental weight, TAC, SIRT1 and Nrf2 with increased placental MDA, Myd88, caspase-3, NF-κB and TNF-α. Histopathological findings of placental damage and high TLR4, FOXO1 immunoexpressions were detected. OCA significantly increased PlGF level, placental weight and normalized the distributed oxidative stress, inflammatory, and apoptotic biomarkers with a prompt improvement in the histopathological picture and decrease TLR4 and FOXO1 immunoexpressions.

Conclusion

Accordingly, these findings suggest that OCA protects CP-induced placental injury by modulating TLR4/Myd88/NF-κB; SIRT1-dependant signaling pathways.

Graphic abstract